Clinical Trials Logo

Dual Anti-platelet Therapy clinical trials

View clinical trials related to Dual Anti-platelet Therapy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04999293 Completed - Clinical trials for Percutaneous Coronary Intervention

Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary Intervention

Start date: July 20, 2021
Phase:
Study type: Observational

The study is an investigator-sponsored, retrospective cohort study designed to compare efficacy and safety of ticagrelor in elderly patients undergoing percutaneous coronary intervention.

NCT ID: NCT03526614 Completed - Clinical trials for Dual Anti-platelet Therapy

REpetitive Assessement of SCOREs in Patients on Dual Antiplatelet Therapy

RE-SCORE
Start date: June 1, 2017
Phase:
Study type: Observational [Patient Registry]

Patients treated with percutaneous coronary intervention (PCI) require dual antiplatelet therapy (DAPT). Preliminary assessment of the PRECISE-DAPT score is mandatory in order to assess the risk of bleeding while on DAPT. The score takes into consideration age, creatinine clearance, haemoglobin, white-blood-cell count and previous spontaneous bleeding. One should consider, however, that some of the variables included in the PRECISE-DAPT score might change with time. As a consequence, the PRECISE-DAPT score should not be considered a static score as it might vary after the initial computation. It remains unknown, however, if the delta PRECISE-SCORE, reflecting the change in score between baseline and follow-up, might predict more reliably the long-term bleeding risk of PCI patients.